Sign In to Request a Protocol
Sign In to Request a Protocol

Adamax (10 mg Vial)

  • Table of Contents

Adamax Research Overview

In educational research, Adamax is administered subcutaneously at doses ranging from 300 micrograms to 1 mg daily. A 10 mg vial reconstituted with antibacterial water yields approximately 3.33 mg per milliliter. This information is for research and educational use only.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
  • Typical daily range: 500–1000 µg once daily (gradual titration).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 µg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 1–2 weeks; avoid freeze–thaw cycles.

Adamax is an adamantane‑modified analog of Semax (N‑acetyl Semax Amidate), a heptapeptide derivative of ACTH(4–10) studied for nootropic and neuroprotective properties. The adamantane moiety enhances blood–brain barrier penetration and peptide stability, yielding greater potency than standard Semax. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

  • Research Information Guide
Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

PhaseDaily Dose (mg)Units (per injection) (mL)
Weeks 1–2300 µg (0.3 mg)9 units (0.09 mL)
Weeks 3–4500 µg (0.5 mg)15 units (0.15 mL)
Weeks 5–6750 µg (0.75 mg)23 units (0.23 mL)
Weeks 7–81000 µg (1.0 mg)30 units (0.30 mL)

Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per‑injection units readable. For the 300 µg starting dose (9 units = 0.09 mL), consider using 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps
  • 1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  • 2. Inject slowly down the vial wall to avoid foaming.
  • 3. Gently swirl or roll the vial until powder fully dissolves (do not shake vigorously).
  • 4. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

  • Research Requirements
Plan based on an 8–16 week daily protocol with gradual titration.
  • Peptide Vials (Adamax, 10 mg each):
  • 8 weeks (gradual dosing): 4 vials (total ~35.7 mg used)
  • 12 weeks (gradual dosing): 7 vials (total ~60.2 mg used)
  • 12 weeks (gradual dosing): 7 vials (total ~60.2 mg used)
  • 16 weeks (gradual dosing): 9 vials (total ~88.2 mg used)
  • Insulin Syringes (U-100):
  • Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes
  • 12 weeks: 84 syringes
  • 16 weeks: 112 syringes
Note: For Week 1–2 dosing (9 units), consider 30-unit or 50-unit syringes for easier measurement precision.
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
  • 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
  • 16 weeks (9 vials): 27 mL → 3 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100-count boxes
  • 16 weeks: 224 swabs → recommend 3 × 100-count boxes
  • Protocol Overview
Concise summary of the subcutaneous regimen.
  • Goal: Goal: Support cognitive enhancement, neuroprotection, and neuroplasticity via BDNF upregulation.
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired), followed by an equal off‑cycle period.
  • Dose Range: 300–1000 µg daily with gradual titration (500 µg is typical mid‑range).
  • Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
  • Research Overview
Suggested daily titration approach.
  • Start: 300 µg daily for 2 weeks (Week 1–2); allows adaptation to peptide effects.
  • Increase: 500 µg daily (Week 3–4), then 750 µg (Week 5–6).
  • Maintenance: 1000 µg daily (Week 7+) for continued nootropic support.
  • Frequency: Once per day (subcutaneous), preferably morning for consistency.
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks with careful monitoring.
  • Off-Cycle: Equal duration break (e.g., 8 weeks on, 8 weeks off) to prevent tolerance.
  • Storage Instructions
Proper storage preserves peptide quality and potency.
  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; keep in original packaging to minimize moisture exposure.
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 1–2 weeks for optimal potency.
  • Avoid Freeze–Thaw: Do not refreeze reconstituted solution; freeze–thaw cycles denature peptides.
  • Allow lyophilized vials to reach room temperature before opening to reduce condensation.
  • Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) daily to reduce local irritation and lipohypertrophy.
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle to prevent leakage.
  • Document daily dose, injection site, and any subjective effects (cognition, mood, sleep) to track response.
  • For doses under 10 units (Week 1–2: 9 units), consider 30‑ or 50‑unit insulin syringes for better precision.
  • How This Works

Adamax is structurally derived from Semax, a well‑studied ACTH(4–10) analog with nootropic properties. Semax increases brain‑derived neurotrophic factor (BDNF) expression and enhances TrkB receptor sensitivity in the hippocampus, promoting neuroplasticity, synaptic formation, and neuronal survival. The peptide modulates neurotransmitter systems (dopamine, serotonin) and activates intracellular signaling cascades (cAMP/CREB pathways), leading to improved memory, learning, and stress resilience. Adamax’s adamantane moiety confers greater lipophilicity and enzymatic stability than Semax, enabling more efficient blood–brain barrier crossing and prolonged in vivo half‑life. This structural enhancement amplifies neuroprotective effects and reduces dosing frequency requirements. Preclinical data suggest 2–3 times greater efficacy in cognitive and endurance outcomes compared to standard Semax.

  • Potential Benefits & Side Effects

Observations from preclinical literature and Semax clinical studies.

Potential Benefits
  • Enhanced cognitive function: improved learning, memory consolidation, and mental clarity.
  • Neuroprotection: supports neuronal survival and recovery in ischemic or oxidative stress models.
  • Mood support: modulates dopamine and serotonin systems, potentially improving stress resilience and reducing anxiety.
  • Neuroplasticity: increases BDNF levels, promoting synaptic growth and neural connectivity.

Potential Benefits

  • Generally well tolerated in Semax studies; no major adverse effects reported in short‑term human trials.
  • Mild injection‑site reactions (redness, itching, minor discomfort) may occur with subcutaneous administration.
  • Limited long‑term human data on Adamax specifically; extrapolated safety from Semax clinical use.
  • No significant IGF‑1 elevation or metabolic disruption observed with Semax‑class peptides.
  • Lifestyle Factors
Complementary strategies for optimizing nootropic outcomes.
  • Pair with a nutrient‑dense diet rich in omega‑3 fatty acids, antioxidants, and B vitamins to support brain health.
  • Engage in regular aerobic exercise and resistance training to enhance BDNF expression synergistically.
  • Prioritize consistent sleep (7–9 hours nightly) for memory consolidation and neural recovery.
  • Practice stress management techniques (meditation, breathwork) to maximize cognitive benefits.
  • Avoid excessive alcohol and processed foods, which may impair neuroplasticity pathways.
  • Scientific Research Information
General subcutaneous guidance from clinical best‑practice resources.
  • Clean the vial stopper with an alcohol swab and allow to dry (~10 seconds).
  • Draw the calculated dose into a sterile insulin syringe; remove air bubbles by gently tapping the syringe.
  • Clean the injection site (abdomen, thigh, or upper arm) with a fresh alcohol swab; allow to dry.
  • Pinch a fold of skin (~1 inch) between thumb and forefinger to elevate subcutaneous tissue.
  • Insert the needle at 45–90° into the skinfold; inject slowly and steadily (do not aspirate).
  • Withdraw the needle and apply gentle pressure with a clean gauze pad; do not massage the site aggressively.
  • Rotate injection sites systematically to prevent lipohypertrophy and ensure consistent absorption.
  • Recommended Source

We recommend Vitality Labs Peptides for high‑purity Adamax (10 mg).

Why Vitality Labs Peptides?

  • High-purity, third-party-tested lots with batch COAs.
  • Consistent, ISO-aligned handling and documentation.
  • Reliable fulfillment to maintain cold-chain integrity.
Contact on Telegram
  • Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. Adamax is a research chemical for laboratory use and is not approved for human consumption. Always consult with a qualified healthcare professional before undertaking any research protocol involving peptides.
  • References

Explore related research dosage protocols and background reading for BPC-157 + TB-500.

PubMed

—Semax: structure, mechanism, and therapeutic potential (ACTH analog overview)
More Info

PMC (NCBI)

— ACTH(4–10) analogs: neuroprotective and cognitive effects
More Info

Medicinal Chemistry Letters

— Adamantane modifications enhance peptide stability and CNS penetration
More Info

Frontiers in Pharmacology (2024)

— NNMT: a novel therapeutic target for metabolic syndrome
More Info

Journal of Neurochemistry (2006)

— Semax binds specific brain sites and increases BDNF protein in rat basal forebrain
More Info

Neuroscience and Behavioral Physiology

— BDNF and TrkB receptor modulation by ACTH analogs (neuroplasticity mechanisms)
More Info

PubMed

— Semax effects on dopamine and serotonin neurotransmission (mood and cognition) View Source
More Info

Bulletin of Experimental Biology and Medicine

— Semax improves learning and memory in animal models
More Info

PubMed

— Neuroprotective effects of Semax in cerebral ischemia models
More Info

PubMed

— Clinical safety and tolerability of Semax in human studies (no major adverse effects)
More Info

CDC

— Vaccine administration: subcutaneous injection technique (angle, sites, and best practices) View Source
More Info

MedlinePlus

— Subcutaneous injections: patient instructions and technique overview
More Info

NCBI Bookshelf

— Injection best practices: site rotation, aseptic technique, and administration protocols
More Info

PMC (Peptide Stability Review)

— Storage and handling of reconstituted peptides: temperature, light protection, and freeze–thaw considerations
More Info

Vitality Lab Peptides

— Adamax (10 mg) product page (quality documentation and supplier information)
More Info